The results of present study could improve the understanding of the role of TTC21A in ccRCC, which make it possible to become a novel biomarker to predict tumor prognosis and immune infiltration for ccRCC patients. The gene discussed is TTC21A; the disease is nonpapillary renal cell carcinoma.